Glycomics/Glycobiology companies

  • Report ID: 2635
  • Published Date: Jun 03, 2025
  • Report Format: PDF, PPT

Companies Dominating the Glycomics/Glycobiology Landscape

    Companies involved in the global market are unfolding remarkable growth opportunities, seeking support from regulatory frameworks. In this regard, the U.S. and Europe-based firms are focusing on biopharmaceutical collaborations to expand their market share. Thermo Fisher and Agilent are leading the market through AI-based glycan platforms that have resulted in a substantial market share reflecting technological adoption. Besides the focus on affordable diagnostics coupled with mergers and acquisitions collectively support the market landscape in this sector.

    Here is the list of some prominent players in the industry:

    Company Name

    Country

    Market Share (2024)

    Thermo Fisher Scientific

    USA

    20%

    Agilent Technologies

    USA

    15%

    Merck KGaA

    Germany

    12%

    Waters Corporation

    USA

    10%

    Shimadzu Corporation

    Japan

    9%

    Bruker Corporation

    USA

    xx%

    Danaher Corporation

    USA

    xx%

    Takara Bio

    Japan

    xx%

    Ludger Ltd

    UK

    xx%

    New England Biolabs

    USA

    xx%

    S-BIO

    South Korea

    xx%

    ProZyme

    USA

    xx%

    GlycoSolutions

    Australia

    xx%

    Dextra Laboratories

    UK

    xx%

    RayBiotech

    USA

    xx%

    Z Biotech

    Germany

    xx%

    Bio-Techne

    USA

    xx%

    Premas Biotech

    India

    xx%

    GlycoNex

    Taiwan

    xx%

    Malaysian Glycomics Consortium

    Malaysia

    xx%

    Below are the areas covered for each company under the top 15 global manufacturers:

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Currently in 2025, the industry revenue of glycomics/glycobiology is evaluated at USD 2.3 billion.

The global glycomics/glycobiology market is set to rise from USD 2.1 billion in 2024 to USD 10.2 billion by 2037, witnessing a CAGR of more than 13.5% throughout the forecast period, between 2025 and 2037.

The North America region glycomics/glycobiology market is projected to register a remarkable revenue share of 45.7% between 2025 and 2037.

The major players in the market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Waters Corporation, Shimadzu Corporation, and other.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos